Man Group PLC Iovance Biotherapeutics, Inc. Transaction History

Man Group PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $523,436 - $1.2 Million	68,964 Added 593.55%	80,583 $1.19 Million
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $201,666 - $543,276	-61,111 Reduced 84.02%	11,619 $94,000
Q3 2023 Nov 14, 2023	SELL	$4.44 - $8.79 $82,455 - $163,239	-18,571 Reduced 20.34%	72,730 $330,000
Q2 2023 Aug 14, 2023	SELL	$5.36 - $9.06 $339,625 - $574,068	-63,363 Reduced 40.97%	91,301 $642,000
Q1 2023 May 15, 2023	BUY	$5.53 - $8.22 $583,746 - $867,703	105,560 Added 214.97%	154,664 $944,000
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $175,113 - $311,590	31,159 Added 173.64%	49,104 $313,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $12,255 - $16,859	-1,286 Reduced 6.69%	17,945 $172,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $122,693 - $352,504	19,231 New	19,231 $212,000
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $6.54 Million - $8.56 Million	-235,704 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $5.93 Million - $8.93 Million	217,854 Added 1220.47%	235,704 $6.47 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $274,888 - $546,541	-14,068 Reduced 44.08%	17,850 $534,000
Q4 2019 Feb 18, 2020	SELL	$17.95 - $29.41 $904,051 - $1.48 Million	-50,365 Reduced 61.21%	31,918 $883,000
Q3 2019 Nov 14, 2019	BUY	$17.99 - $26.0 $1.48 Million - $2.14 Million	82,283 New	82,283 $1.5 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.46B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.